MeSH tree: C14.280.484
The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Approval of Myqorzo was granted to Cytokinetics.
Jan 6, 2026
0
0
Aortic stenosis is a narrowing of the aortic valve, which connects the heart to the rest of the body. It affects millions of people and can be fatal if left untreated. At present, there are no effective medical therapies ...
Dec 20, 2025
0
22
Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat valvular heart disease significantly improved survival.
Dec 11, 2025
0
0
Sudden cardiac arrest may occur in various conditions when someone, while active (playing basketball or walking with friends), collapses and passes out. Their blood pressure drops, and often their heart stops. This may be ...
Dec 10, 2025
0
0
Preparing for surgery can be scary. In addition to the medical issues, having surgery involves a lot of prep. You may need to coordinate childcare, transportation, finances and time off work. Designate a caregiver. Stop taking ...
Nov 20, 2025
0
0
The first ever "humanized" model for aortic valve calcification paves the way for testing potential treatments.
Nov 12, 2025
0
0
Chest pain may still be angina even when coronary angiogram testing shows the main heart arteries look clear. Using stress cardiac stress MRI testing to measure blood flow around the heart appears to improve diagnosis and ...
Nov 10, 2025
0
0
People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial participation and speed diagnosis ...
Nov 5, 2025
0
0
David Daniels, M.D., an interventional cardiologist with Sutter West Bay Medical Group and structural heart section chief of Sutter's Advanced Heart & Vascular Service Line, presented results of the international ENCIRCLE ...
Oct 29, 2025
0
0
People who underwent a minimally invasive procedure to have their heart's aortic valve replaced had similar health outcomes years after treatment as people who had surgery, Cedars-Sinai investigators and colleagues report.
Oct 28, 2025
0
11
